CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.85B, above the global median of $1.18B
- FinancialsAltman Z-Score 3.51: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.39%Below 5Y avg (1.83%)
Annual Rate
CNY 0.09Paid annual
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
May 12, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
12.39BCNY1.85B · vs all stocks (USD)
Revenue (TTM)
3.59BCNY535.52M · vs all stocks (USD)
Profit Margin
-4.32%Beta
0.5160xvs all stocks
52-Week Change
-13.64%vs all stocks
Market Capitalization
12.39BCNY1.85B · vs all stocks (USD)
Enterprise Value
12.48BCNY1.86B · vs all stocks (USD)
Forward P/E
39.29xPrice to Sales (TTM)
3.45xPrice to Book (MRQ)
2.47xEnterprise to Revenue
3.48xEnterprise to EBITDA
23.57xGross Margin
33.84%Profit Margin
-4.32%Operating Margin
8.02%Return on Assets (TTM)
1.42%Return on Equity (TTM)
-4.16%Revenue (TTM)
3.59BCNY535.52M · vs all stocks (USD)
Revenue per Share (TTM)
6.67CNYUpdated Sep 20, 2026Quarterly Revenue Growth
10.30%Gross Profit (TTM)
1.13BCNY168.13M · vs all stocks (USD)
EBITDA (TTM)
607.65MCNY90.67M · vs all stocks (USD)
Net Income (TTM)
-154.92MCNY-23.12M · vs all stocks (USD)
Operating Cash Flow (TTM)
812.53MCNY121.25M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
398.42MCNY59.45M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0900CNYUpdated Sep 20, 2026Trailing Annual Dividend Yield
0.39%vs all stocks
5-Year Average Dividend Yield
1.83%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
147.44MCNYFY2025 · Dec 31, 2025Revenue
3.42BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.40BCNYFY2025 · Dec 31, 2025Gross Profit
1.02BCNYFY2025 · Dec 31, 2025Operating Income
211.03MCNY31.49M · vs all stocks (USD)
Pre-tax Income
82.68MCNYFY2025 · Dec 31, 2025Income Tax Expense
52.29MCNYFY2025 · Dec 31, 2025Net Income
30.39MCNYFY2025 · Dec 31, 2025EBIT
133.15MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
607.65MCNYFY2025 · Dec 31, 2025Research & Development
267.58MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
188.03MCNYFY2025 · Dec 31, 2025Other Operating Expenses
32.34MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
9.07MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
50.48MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1800CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1800CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
535.22MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
535.22MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
30.39MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
65.95MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
75.29MCNYFY2025 · Dec 31, 2025Free Cash Flow
-213.33MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.03BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
30.39MCNYFY2025 · Dec 31, 2025Other Non-cash Items
126.35MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-80.21MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-1.24MCNYFY2025 · Dec 31, 2025Capital Expenditures
-288.61MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.26BCNYFY2025 · Dec 31, 2025Sale of Investments
1.87BCNYFY2025 · Dec 31, 2025Other Investing Activity
2.56MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-677.84MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
220.41MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-604.01MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-30.11MCNYFY2025 · Dec 31, 2025Other Financing Charges
-80.21MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-493.92MCNYFY2025 · Dec 31, 2025Shares Outstanding
543.44MSharesUpdated Sep 20, 2026Float Shares
311.55MSharesUpdated Sep 20, 2026% Held by Insiders
44.72%vs all stocks
% Held by Institutions
5.81%vs all stocks
Total Cash (MRQ)
1.14BCNY169.76M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.12CNYUpdated Sep 20, 2026Total Debt (MRQ)
1.28BCNY191.30M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2527xCurrent Ratio (MRQ)
2.00xBook Value per Share (MRQ)
9.24CNYUpdated Sep 20, 2026Total Assets
8.55BCNY1.28B · vs all stocks (USD)
Total Current Assets
3.27BCNYFY2025 · Dec 31, 2025Total Liabilities
3.05BCNYFY2025 · Dec 31, 2025Total Non-current Assets
5.28BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.26BCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.80BCNYFY2025 · Dec 31, 2025Cash
1.12BCNYFY2025 · Dec 31, 2025Cash Equivalents
8.59MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.13BCNYFY2025 · Dec 31, 2025Other Short-term Investments
279.28MCNYFY2025 · Dec 31, 2025Accounts Receivable
762.37MCNYFY2025 · Dec 31, 2025Inventory
770.38MCNYFY2025 · Dec 31, 2025Accounts Payable
844.70MCNYFY2025 · Dec 31, 2025Short-term Debt
496.99MCNYFY2025 · Dec 31, 2025Other Current Liabilities
8.94MCNYFY2025 · Dec 31, 2025Long-term Debt
1.01BCNYFY2025 · Dec 31, 2025Common Stock (Book)
543.44MCNYFY2025 · Dec 31, 2025Retained Earnings
2.57BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
5.50BCNY820.43M · vs all stocks (USD)
Treasury Stock
29.87MCNYFY2025 · Dec 31, 202552-Week Low
13.24CNYUpdated Sep 20, 202652-Week High
30.40CNYUpdated Sep 20, 202652-Week Change
-13.64%vs all stocks
Beta
0.5160xvs all stocks
50-Day MA
19.39CNYUpdated Sep 20, 2026200-Day MA
20.46CNYUpdated Sep 20, 2026Avg 10-Day Volume
23.07MSharesUpdated Sep 20, 2026Avg 30-Day Volume
32.88MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
-0.2800CNYUpdated Sep 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.51: safe zoneNotable
Altman Z-Score: 3.51
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.85B, above the global median of $1.18BNotable
Market cap (USD): 1,848,096,741.841Global Median: 1,180,223,658.953
Levered free cash flow is $59.45M, above the global median of $18.73MNotable
Levered free cash flow (USD): 59,452,370.876Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Ascletis Pharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Mirxes Holding Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
MeHow Innovative Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Novocure Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zhejiang Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Cofoe Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Fagron NV
Tier 1ProductionApproval-Gated PipelineFlowRule
Chengdu Olymvax Biopharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Mabwell (Shanghai) Bioscience Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Wedge Industrial Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule